PSTC Paper Provides Inside Look at FDA and EMEA Biomarker Approval Process
May 14, 2010
PSTC Paper Provides Inside Look at FDA and EMEA Biomarker Approval Process
An FDA official said that the agency has formalized the "progressive" biomarker qualification process described in the paper and will be releasing a draft guidance detailing the formal steps of the process this July.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Yale-Led Group Links Protein Markers to Kidney Injury in Cardiac Surgery Patients
August 26, 2011 / ProteoMonitor - FDA Delays Release of Guidance on Biomarker Qualification; Aims to Publish by End of Year
September 3, 2010 / ProteoMonitor - Japanese Regulators Approve Critical Path's Protein Biomarker Panel for Drug Toxicity Studies
June 25, 2010 / ProteoMonitor - Big Pharma Exploring Targeted MS to Measure Key Transporter Proteins for Drug Development
August 12, 2011 / ProteoMonitor - Correlogic Developing 'Second Generation' OvaCheck; Seeks Ruling on Quest, LabCorp Licenses
July 8, 2011 / ProteoMonitor